156 related articles for article (PubMed ID: 28017877)
1. Negative regulation of HLA-DR expression on endothelial cells by anti-blood group A/B antibody ligation and mTOR inhibition.
Iwasaki K; Miwa Y; Uchida K; Kodera Y; Kobayashi T
Transpl Immunol; 2017 Feb; 40():22-30. PubMed ID: 28017877
[TBL] [Abstract][Full Text] [Related]
2. Comparative study on signal transduction in endothelial cells after anti-a/b and human leukocyte antigen antibody reaction: implication of accommodation.
Iwasaki K; Miwa Y; Ogawa H; Yazaki S; Iwamoto M; Furusawa T; Onishi A; Kuzuya T; Haneda M; Watarai Y; Uchida K; Kobayashi T
Transplantation; 2012 Feb; 93(4):390-7. PubMed ID: 22222784
[TBL] [Abstract][Full Text] [Related]
3. The suppressive effect on CD4 T cell alloresponse against endothelial HLA-DR via PD-L1 induced by anti-A/B ligation.
Iwasaki K; Hamana H; Kishi H; Yamamoto T; Hiramitsu T; Okad M; Tomosugi T; Takeda A; Narumi S; Watarai Y; Miwa Y; Okumura M; Matsuoka Y; Horimi K; Muraguchi A; Kobayash T
Clin Exp Immunol; 2020 Nov; 202(2):249-261. PubMed ID: 32578199
[TBL] [Abstract][Full Text] [Related]
4. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
[TBL] [Abstract][Full Text] [Related]
5. Interferon-γ-induced HLA Class II expression on endothelial cells is decreased by inhibition of mTOR and HMG-CoA reductase.
Maenaka A; Kenta I; Ota A; Miwa Y; Ohashi W; Horimi K; Matsuoka Y; Ohnishi M; Uchida K; Kobayashi T
FEBS Open Bio; 2020 May; 10(5):927-936. PubMed ID: 32237049
[TBL] [Abstract][Full Text] [Related]
6. HLA class II antibodies induce necrotic cell death in human endothelial cells via a lysosomal membrane permeabilization-mediated pathway.
Aljabri A; Vijayan V; Stankov M; Nikolin C; Figueiredo C; Blasczyk R; Becker JU; Linkermann A; Immenschuh S
Cell Death Dis; 2019 Mar; 10(3):235. PubMed ID: 30850581
[TBL] [Abstract][Full Text] [Related]
7. Lower incidence of de novo donor-specific antibodies against HLA-DR in ABO-incompatible renal transplantation.
Okada M; Watarai Y; Iwasaki K; Futamura K; Yamamoto T; Hiramitsu T; Tsujita M; Goto N; Narumi S; Takeda A; Kobayashi T
Hum Immunol; 2019 Mar; 80(3):169-175. PubMed ID: 30552908
[TBL] [Abstract][Full Text] [Related]
8. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway.
Narayanan K; Jendrisak MD; Phelan DL; Mohanakumar T
Transpl Immunol; 2006 Jan; 15(3):187-97. PubMed ID: 16431285
[TBL] [Abstract][Full Text] [Related]
9. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial cells evade apoptosis triggered by human leukocyte antigen-DR ligation mediated by allospecific antibodies.
Le Bas-Bernardet S; Coupel S; Chauveau A; Soulillou JP; Charreau B
Transplantation; 2004 Dec; 78(12):1729-39. PubMed ID: 15614145
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of the endothelial tie-2 crossmatch in ABO compatible and ABO incompatible renal transplants.
Kafetzi ML; Boletis JN; Melexopoulou CA; Tsakris A; Iniotaki AG; Doxiadis II
Hum Immunol; 2013 Nov; 74(11):1425-30. PubMed ID: 23792052
[TBL] [Abstract][Full Text] [Related]
12. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
[TBL] [Abstract][Full Text] [Related]
13. The fate of renal allografts hinges on responses of the microvascular endothelium.
Mannam VK; Lewis RE; Cruse JM
Exp Mol Pathol; 2013 Apr; 94(2):398-411. PubMed ID: 22710034
[TBL] [Abstract][Full Text] [Related]
14. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
15. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
Bućin D; Johansson S; Lindberg LO
Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
[TBL] [Abstract][Full Text] [Related]
16. Accommodation: does it apply to human leukocyte antigens?
Rose ML; West LJ
Transplantation; 2012 Feb; 93(3):244-6. PubMed ID: 22167050
[TBL] [Abstract][Full Text] [Related]
17. De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation.
Koch M; Wiech T; Marget M; Peine S; Thude H; Achilles EG; Fischer L; Lehnhardt A; Thaiss F; Nashan B
Clin Transplant; 2015 Nov; 29(11):1021-8. PubMed ID: 26333844
[TBL] [Abstract][Full Text] [Related]
18. Molecular Mechanisms of Antibody-Mediated Rejection and Accommodation in Organ Transplantation.
Kenta I; Takaaki K
Nephron; 2020; 144 Suppl 1():2-6. PubMed ID: 33238285
[TBL] [Abstract][Full Text] [Related]
19. Endothelial permeability is increased by the supernatant of peripheral blood mononuclear cells stimulated with HLA Class II antibody.
Wakamoto S; Fujihara M; Sakagawa H; Takahashi D; Niwa K; Morioka M; Sato S; Kato T; Azuma H; Ikeda H
Transfusion; 2008 Oct; 48(10):2060-8. PubMed ID: 18564388
[TBL] [Abstract][Full Text] [Related]
20. Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and Qs.
Cross AR; Lion J; Loiseau P; Charron D; Taupin JL; Glotz D; Mooney N
Hum Immunol; 2016 Nov; 77(11):1092-1100. PubMed ID: 27060781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
